The synthesis of complex pharmaceutical compounds, such as the broad-spectrum antibiotic Moxifloxacin, is a multi-step process where the quality of each intermediate plays a pivotal role. For pharmaceutical manufacturers and formulation scientists, understanding the specifications and sourcing strategy for key intermediates like 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid is vital for optimizing production yields and ensuring the final API's purity and efficacy.

The Significance of 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic Acid in Moxifloxacin Production

This specific chemical entity, often identified by its CAS number 112811-72-0, is a direct precursor in the manufacturing pathway of Moxifloxacin and its hydrochloride salt. Its structural integrity, purity, and consistent supply directly influence:

  • Reaction Yield: A high-purity intermediate leads to higher conversion rates in subsequent synthetic steps, maximizing the output of the desired API.
  • API Purity: Impurities present in the intermediate can carry through the synthesis, necessitating more complex and costly purification procedures or even rendering the final product unacceptable for pharmaceutical use.
  • Process Efficiency: Consistent quality reduces batch-to-batch variability, leading to more predictable and efficient manufacturing processes.
  • Regulatory Compliance: Meeting stringent regulatory requirements for APIs necessitates the use of well-characterized and high-purity raw materials.

When you plan to buy this critical intermediate, looking for a manufacturer with a proven track record in producing high-purity chemicals is essential. We provide this compound with an assay of ≥98.5% and low impurity levels, ensuring it meets the exacting standards of the pharmaceutical industry.

Sourcing Strategy for Pharmaceutical Professionals

For procurement managers and R&D chemists, the selection of a supplier for 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid should involve a thorough evaluation of several factors:

  • Product Specifications: Confirming appearance (white or off-white powder), purity (≥99%), and adherence to impurity profiles is paramount.
  • Technical Support: A responsive technical team can provide critical data and support for process integration.
  • Supply Reliability: Ensuring a stable supply chain, especially from reputable manufacturers in regions like China, is key to uninterrupted production.
  • Pricing and Value: While quality is paramount, competitive price is also a consideration for cost-effective manufacturing.

As a dedicated manufacturer and supplier, we are committed to supporting the pharmaceutical industry by offering 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid that meets the highest quality benchmarks. We invite you to contact us to request a quote and discuss how our product can enhance your Moxifloxacin synthesis operations. Secure your supply from a trusted partner to ensure the success of your pharmaceutical development.